会员体验
专利管家(专利管理)
工作空间(专利管理)
风险监控(情报监控)
数据分析(专利分析)
侵权分析(诉讼无效)
联系我们
交流群
官方交流:
QQ群: 891211   
微信请扫码    >>>
现在联系顾问~
热词
    • 1. 发明授权
    • HALOGENATED AMIDINO AMINO ACID DERIVATIVES USEFUL AS NITRIC OXIDE SYNTHASE INHIBITORS
    • 致癌氨基酸衍生物ALS HEMMSTOFFE DER STICKSTOFFMONOXID-SYNTHASE
    • EP1062201B1
    • 2004-09-29
    • EP99908324.9
    • 1999-03-04
    • G.D. SEARLE & CO.
    • HALLINAN, E., AnnPITZEL, Barnett, S.SPANGLER, Dale, P.BERGMANIS, Arija, A.HAGEN, Timothy, J.TSYMBALOV, SofyaTOTH, Mihaly, V.WEBBER, R., KeithHANSEN, Donald, W., Jr.AWASTHI, Alik, K.
    • C07C257/14C07C323/58C07D333/24A61K31/38A61K31/55
    • C07D333/24C07C257/14C07C323/58C07C2601/02
    • Halogenated amidino aminoacid derivatives (I) are new. Aminoacid derivatives of formula (I) and their salts are new. [Image] R1H, alkyl, alkenyl or alkynyl; R2as R1 or R- or S-alpha -aminoacid; R3, R4as R1 or NO2; R1-R4 are optionally substituted by T; T : lower alkyl, lower alkenyl, lower alkynyl, cycloalkyl, heterocyclyl, aryl, heteroaryl, OH, lower alkoxy, aryloxy, SH, lower thioalkoxy, halo, CN, NO2, NH2, COOH, carboxyalkyl, carboxyaryl, amidino or guanidino; R11OH or R- or S-alpha -aminoacid; G : (i) 1-10C alkylene, 2-10C alkenylene or 2-10C alkynylene (all optionally substituted by one or more of halo, OH, CF3, NO2, CN, NH2, =CH2, alkyl, alkenyl, alkynyl or alkoxy (all optionally substituted by T or CF3)); (ii) (CH2)p(CX1X2)r(CH2)sQ(CH2)t(CX3X4)u(CH2)v; or (iii) (CH2)q(CX5X6)y(CH2)zA(CH2)k(CX7X8)j(CH2)h; p, r, s, t, u, v, w, y, z, k, j, h : 0-3; Q : Q = O, CO, S(O)a or NR12; a : 0-2, provided that if a = 1-2 then G must contain halo; R12H or alkyl (optionally substituted by alkyl, alkoxy, OH, CF3, NO2, CN, NH2 or halo); A : 3-6-membered carbocyclic or heterocyclic residue (optionally substituted by one or more of halo, alkyl, alkoxy, OH, CF3, NO2, CN or NH2); X1-X8H or halo; or alkyl, CH2, alkenyl or alkynyl (all optionally substituted by T or CF3); Y : heterocycle, mono-, di- or tri-haloalkyl, alkyl, cycloalkyl, alkenyl or alkynyl (all optionally substituted by one or more of halo, OH, CF3, NO2, CN, NH2, alkyl, alkenyl, alkynyl and alkoxy); or NR9R10; R9, R10H, alkyl, cycloalkyl, alkenyl, alkynyl, NO2, NH2, aryl or alkaryl; unless specified otherwise alkyl moieties have 1-10C, alkenyl or alkynyl moieties 2-10C and cycloalkyl moieties 3-10C; provided that at least one of G and Y contains a halogen; and that if G = (iii) then Y must contain halogen. ACTIVITY : Hypertensive; antiinflammatory; immunomodulatory; antidiabetic; cardiovascular; gastrointestinal; dermatological; bronchodilatory; anticancer; analgesic. MECHANISM OF ACTION : Inducible nitric oxide synthase (iNOS) inhibitor.
    • 卤代脒基氨基酸衍生物(I)是新的。 式(I)的氨基酸衍生物及其盐是新的。 R1H,烷基,烯基或炔基; R2as R1或R-或S-α-氨基酸; R3,R4as R1或NO2; R1-R4任选被T取代; 低级烷基,低级烯基,低级炔基,环烷基,杂环基,芳基,杂芳基,OH,低级烷氧基,芳氧基,SH,低级硫代烷氧基,卤素,CN,NO2,NH2,COOH,羧基烷基,羧基芳基,脒基或胍基; R11OH或R-或S-α-氨基酸; G:(i)1-10C亚烷基,2-10C亚烯基或2-10C亚炔基(全部任选被一个或多个卤素,OH,CF 3,NO 2,CN,NH 2,= CH 2,烷基,烯基,炔基或烷氧基取代 (全部由T或CF 3取代)); (ⅱ)(CH2)p(CX1X2)r(CH2)sQ(CH2)t(CX3X4)u(CH2)v; 或(iii)(CH 2)q(CX 5 X 6)y(CH 2)z A(CH 2)k(CX 7 X 8)j(CH 2)h; p,r,s,t,u,v,w,y,z,k,j,h:0-3; Q:Q = O,CO,S(O)a或NR12; a:0-2,条件是如果a = 1-2,那么G必须包含光环; R12H或烷基(任选被烷基,烷氧基,OH,CF 3,NO 2,CN,NH 2或卤素取代); A:3-6元碳环或杂环残基(任选被卤素,烷基,烷氧基,OH,CF 3,NO 2,CN或NH 2中的一个或多个取代); X1-X8H或卤素; 或烷基,CH 2,烯基或炔基(全部被T或CF 3取代); Y:杂环,单 - ,二 - 或三 - 卤代烷基,烷基,环烷基,烯基或炔基(全部被卤素,OH,CF 3,NO 2,CN,NH 2,烷基,烯基,炔基和烷氧基中的一个或多个取代) ; 或NR9R10; R9,R10H,烷基,环烷基,烯基,炔基,NO2,NH2,芳基或烷芳基; 除非另有说明,烷基部分具有1-10C,链烯基或炔基部分2-10C和环烷基部分3-10C; G和Y中的至少一个含有卤素; 并且如果G =(iii)则Y必须含有卤素。 活动:高血压; 抗炎; 免疫调节; 降糖; 心血管疾病; 胃肠道; 皮肤; 支气管扩张; 抗癌; 镇痛药。 作用机制:诱导型一氧化氮合酶(iNOS)抑制剂。
    • 4. 发明公开
    • HALOGENATED AMIDINO AMINO ACID DERIVATIVES USEFUL AS NITRIC OXIDE SYNTHASE INHIBITORS
    • 卤化氨基衍生物硝酸合酶抑制剂的
    • EP1062201A2
    • 2000-12-27
    • EP99908324.9
    • 1999-03-04
    • G.D. SEARLE & CO.
    • HALLINAN, E., AnnPITZEL, Barnett, S.SPANGLER, Dale, P.BERGMANIS, Arija, A.HAGEN, Timothy, J.TSYMBALOV, SofyaTOTH, Mihaly, V.WEBBER, R., KeithHANSEN, Donald, W., Jr.AWASTHI, Alik, K.
    • C07C257/14C07C323/58C07D333/24A61K31/38A61K31/55
    • C07D333/24C07C257/14C07C323/58C07C2601/02
    • Halogenated amidino aminoacid derivatives (I) are new. Aminoacid derivatives of formula (I) and their salts are new. [Image] R1H, alkyl, alkenyl or alkynyl; R2as R1 or R- or S-alpha -aminoacid; R3, R4as R1 or NO2; R1-R4 are optionally substituted by T; T : lower alkyl, lower alkenyl, lower alkynyl, cycloalkyl, heterocyclyl, aryl, heteroaryl, OH, lower alkoxy, aryloxy, SH, lower thioalkoxy, halo, CN, NO2, NH2, COOH, carboxyalkyl, carboxyaryl, amidino or guanidino; R11OH or R- or S-alpha -aminoacid; G : (i) 1-10C alkylene, 2-10C alkenylene or 2-10C alkynylene (all optionally substituted by one or more of halo, OH, CF3, NO2, CN, NH2, =CH2, alkyl, alkenyl, alkynyl or alkoxy (all optionally substituted by T or CF3)); (ii) (CH2)p(CX1X2)r(CH2)sQ(CH2)t(CX3X4)u(CH2)v; or (iii) (CH2)q(CX5X6)y(CH2)zA(CH2)k(CX7X8)j(CH2)h; p, r, s, t, u, v, w, y, z, k, j, h : 0-3; Q : Q = O, CO, S(O)a or NR12; a : 0-2, provided that if a = 1-2 then G must contain halo; R12H or alkyl (optionally substituted by alkyl, alkoxy, OH, CF3, NO2, CN, NH2 or halo); A : 3-6-membered carbocyclic or heterocyclic residue (optionally substituted by one or more of halo, alkyl, alkoxy, OH, CF3, NO2, CN or NH2); X1-X8H or halo; or alkyl, CH2, alkenyl or alkynyl (all optionally substituted by T or CF3); Y : heterocycle, mono-, di- or tri-haloalkyl, alkyl, cycloalkyl, alkenyl or alkynyl (all optionally substituted by one or more of halo, OH, CF3, NO2, CN, NH2, alkyl, alkenyl, alkynyl and alkoxy); or NR9R10; R9, R10H, alkyl, cycloalkyl, alkenyl, alkynyl, NO2, NH2, aryl or alkaryl; unless specified otherwise alkyl moieties have 1-10C, alkenyl or alkynyl moieties 2-10C and cycloalkyl moieties 3-10C; provided that at least one of G and Y contains a halogen; and that if G = (iii) then Y must contain halogen. ACTIVITY : Hypertensive; antiinflammatory; immunomodulatory; antidiabetic; cardiovascular; gastrointestinal; dermatological; bronchodilatory; anticancer; analgesic. MECHANISM OF ACTION : Inducible nitric oxide synthase (iNOS) inhibitor.